Evidence map›Paper›PMID 18835817›Full record

ArticleThe Journal of biological chemistry2008

A disease-causing point mutation in human mitochondrial tRNAMet rsults in tRNA misfolding leading to defects in translational initiation and elongation.

Christie N Jones, Christopher I Jones, William D Graham, Paul F Agris, Linda L Spremulli

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Genome-wide analysis of theProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  6. Structural basis for impaired 5' processing of a mutant tRNA associated with defects in neuronal homeostasis.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  7. Single-nucleotide control of tRNA folding cooperativity under near-cellular conditions.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. RNA modification enzyme TruB is a tRNA chaperone.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Christie N JonesDepartment of Chemistry, University of North Carolina, Chapel Hill, North Carolina 27599, USA.
Christopher I Jones
William D Graham
Paul F Agris
Linda L Spremulli
University of North Carolina at Chapel Hill · USNorth Carolina State University · US

Funding

MECHANISM OF PROTEIN SYNTHESIS IN MAMMALIAN MITOCHONDRIAR01GM032734 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SPREMULLI, LINDA L · 1985 to 2009
$2.8M
TRANSFER RNA STRUCTURE DURING PROTEIN SYNTHESISR01GM023037 · NIGMS · UNIVERSITY OF MISSOURI-COLUMBIA · PI AGRIS, PAUL F · 1985 to 2010
$1.3M
NIGMS NIH HHS GM23037NIGMS NIH HHS GM32734
6 · The paper itself

Abstract

The mitochondrial tRNA genes are hot spots for mutations that lead to human disease. A single point mutation (T4409C) in the gene for human mitochondrial tRNA(Met) (hmtRNA(Met)) has been found to cause mitochondrial myopathy. This mutation results in the replacement of U8 in hmtRNA(Met) with a C8. The hmtRNA(Met) serves both in translational initiation and elongation in human mitochondria making this tRNA of particular interest in mitochondrial protein synthesis. Here we show that the single 8U-->C mutation leads to a failure of the tRNA to respond conformationally to Mg(2+). This mutation results in a drastic disruption of the structure of the hmtRNA(Met), which significantly reduces its aminoacylation. The small fraction of hmtRNA(Met) that can be aminoacylated is not formylated by the mitochondrial Met-tRNA transformylase preventing its function in initiation, and it is unable to form a stable ternary complex with elongation factor EF-Tu preventing any participation in chain elongation. We have used structural probing and molecular reconstitution experiments to examine the structures formed by the normal and mutated tRNAs. In the presence of Mg(2+), the normal tRNA displays the structural features expected of a tRNA. However, even in the presence of Mg(2+), the mutated tRNA does not form the cloverleaf structure typical of tRNAs. Thus, we believe that this mutation has disrupted a critical Mg(2+)-binding site on the tRNA required for formation of the biologically active structure. This work establishes a foundation for understanding the physiological consequences of the numerous mitochondrial tRNA mutations that result in disease in humans.

Indexed as

Point MutationAnimalsBase SequenceBinding SitesCattleEscherichia coliHumansMitochondriaMutationNucleic Acid ConformationNucleic Acid DenaturationOptic Atrophy, Hereditary, LeberProtein BiosynthesisRNA, Transfer, MetThermodynamicsRNA, Transfer, Met

Identifiers

PMID18835817
PMCPMC2590712
OpenAlexW2144566034

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.